mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting
Precision oncology is evolving with personalized mRNA neoantigen vaccines, although long-term clinical responses vary. These mRNA-based vaccines have facilitated the development of patient-specific neoantigens. Clinical success is dependent not only on immunogenicity but also on tumor neoantigen clo...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2026-12-01
|
| Ráidu: | Molecular & Cellular Oncology |
| Fáttát: | |
| Liŋkkat: | https://www.tandfonline.com/doi/10.1080/23723556.2026.2652613 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|